Evaluation of adrenal masses in patients with bronchogenic carcinoma using 18F-fluorodeoxy-glucose positron emission tomography

American Journal of Roentgenology

Volumn 168, Issue 5, 1997, Pages 1357-1362

  Erasmus, Jeremy J ^a   Patz Jr , Edward F ^a   McAdams, H Page ^a   Murray, John G ^a   Herndon, James ^a   Coleman, R Edward ^a   Goodman, Philip C ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADRENAL METASTASIS; ADRENAL TUMOR; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC VALUE; FEMALE; HUMAN; LUNG CARCINOMA; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PERCUTANEOUS BIOPSY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIATION ATTENUATION;

EID: 0030932730     PISSN: 0361803X     EISSN: None     Source Type: Journal    
DOI: 10.2214/ajr.168.5.9129444     Document Type: Article

References (35)

1. Englemen RM, McNamara WL, Bronchogenic carcinoma: a statistical review of two hundred twenty-four autopsies. J Thorac Surg 1954;27:227-237
2. Klein JS, Webb WR. The radiologic staging of lung cancer. J Thorac Imaging 1991;7:29-47
3. Oliver TW Jr, Bernardino ME, Miller JI, Mansour K, Greene D, Davis WA. Isolated adrenal masses in nonsmall-cell bronchogenic carcinoma. Radiology 1984;153:217-218
4. Singer AA, Obuchowski NA, Einstein DM, Paushter DM. Metastasis or adenoma? Computed tomographic evaluation of the adrenal mass. Cleve Clin J Med 1994;61:200-205
5. Sandler MA, Pearlberg JL, Madrazo BL, Gitschlag KF, Gross SC. Computed tomographic evaluation of the adrenal gland in the preoperative assessment of bronchogenic carcinoma Radiology 1982;145:733-736
6. Pagani JJ. Non-small cell lung carcinoma adrenal metastases. Cancer 1984;53:1058-1060
7. Pagani JJ. Normal adrenal glands in small cell lung carcinoma: CT-guided biopsy. AJR 1983;140:949-951
8. Nielsen ME Jr, Heaston DK, Dunnick NR, Korobkin M. Preoperative CT evaluation of adrenal glands in non-small cell bronchogenic carcinoma. AJR 1982;139:317-320
9. McNicholas MM, Lee MJ, Mayo-Smith WW, et al. An imaging algorithm for the differential diagnosis of adrenal adenomas and metastases. AJR 1995;165:1453-1459
10. Glazer GM, Woolsey EJ, Borrello J, et al. Adrenal tissue characterization using MR imaging. Radiology 1986;158:73-79
11. Lee MJ, Hahn PF, Papanicolaou N, et al. Benign and malignant adrenal masses: CT distinction with attenuation coefficients, size, and observer analysis. Radiology 1991;179:415-418
12. Reinig JW, Doppman JL, Dwyer AJ, Johnson AR, Knop RH. Adrenal masses differentiated by MR. Radiology 1986;158:81-84
13. Schwartz LH, Panicek DM, Koutcher JA, et al. Adrenal masses in patients with malignancy: prospective comparison of echo-planar, fast spin-echo, and chemical shift MR imaging. Radiology 1995;197:421-425
14. Gupta NC, Frank AR, Dewan NA, et al. Solitary pulmonary nodules: detection of malignancy with PET with 2-[F-18]-fluoro-2-deoxy-D-glucose. Radiology 1992;184:441-444
15. Patz EF Jr, Lowe VJ, Hoffman JM, et al. Focal pulmonary abnormalities: evaluation with F-18 fluorodeoxyglucose PET scanning. Radiology 1993;188: 487-490
16. Wahl RL, Quint LE, Greenough RL, Meyer CR, White RI, Orringer MB. Staging of mediastinal non-small cell lung cancer with FDG PET, CT, and fusion images: preliminary prospective evaluation. Radiology 1994;191:371-377
17. 18FDG in patients with bronchogenic carcinoma. Chest 1995;108:1617-1621
18. Sazon DAD, Santago SM, Hoo GWS, et al. Fluorodeoxyglucose-positron emission tomography in the detection and staging of lung cancer. Am J Reapir Crit Care Med 1996;153:417-421
19. Valk PE, Pounds TR, Hopkins DM, et al. Staging non-small cell lung cancer by whole-body positron emission tomographic imaging. Ann Thorac Surg 1995;60:1573-1582
20. Boland GW, Goldberg MA, Lee MJ, et al. Indeterminate adrenal mass in patients with cancer: evaluation at PET with 2-[F-18]-fluoro-2-deoxy-D-glucose. Radiology 1995;194:131-134
21. Patz EF, Lowe VJ, Hoffman JM, Paine SS, Harris KK, Goodman PC. Persistent or recurrent bronchogenic carcinoma: detection with PET and 2-[F-18]-2-deoxy-d-glucose. Radiology 1994;191:379-382
22. DeGrado TR, Turkington TG, Williams JJ, Stearns CW, Hoffman JM, Coleman RE. Performance characteristics of a whole-body PET scanner. J Nucl Med 1994;35:1398-1406
23. Hamacher K, Coenen HH, Stocklin G. Efficient stereospecific synthesis of no-carrier-added 2-[18F]-fluoro-2-deoxy-D-glucose using aminopolyether supported nucleophilic substitution. J Nucl Med 1986;27:235-238
24. Boring CC, Squires TS, Tong T. Cancer statistics, 1993. CA Cancer J Clin 1993;43:7-23
25. Passlick B, Izbicki JR, Kubuschok B, Thetter O, Pantel K. Detection of disseminated lung cancer cells in lymph nodes: impact on staging and prognosis. Ann Thorac Surg 1996;61:177-183
26. Ettinghausen SE, Burt ME. Prospective evaluation of unilateral adrenal masses in patients with operable non-small-cell lung cancer. J Clin Oncol 1991; 9:1462-1466
27. Commons RR, Callaway CP. Adenomas of the adrenal cortex. Arch Intern Med 1948;81:37-41
28. Copeland PM. The incidentally discovered adrenal mass. Ann Intern Med 1983;98:940-945.
29. Mitchell DG, Crovello M, Matteucci T, Petersen RO, Miettinen MM. Benign adrenocortical masses: diagnosis with chemical shift MR imaging. Radiology 1992;185:345-351
30. Bernardino ME, Walther MM, Phillips VM, et al. CT-guided adrenal biopsy: accuracy, safety, and indications. AJR 1985;144:67-69
31. Bernardino ME. Management of the asymptomatic patient with a unilateral adrenal mass. Radiology 1988;166:121-123
32. 18F-2-deoxy-2-fluoro-D-glucose uptake into human tumor xenografts: feasibility studies for cancer imaging with positron emission tomography. Cancer 1991;67:1544-1550
33. 18F] 2-deoxy-2-fluoro-D-glucose. J Nucl Med 1978;19:1154-1161
34. Lowe VJ, Hoffman JM, DeLong DM, Patz EF, Coleman RE. Semiquantitative and visual analysis of FDG-PET images in patients with pulmonary abnormalities. J Nucl Med 1994;35:1771-1776
35. Rege SD, Hoh CK, Glaspy JA. Imaging of pulmonary mass lesions with whole-body positron emission tomography and fluoro-deoxyglucose. Cancer 1993;72:82-90